IL75597A - Synergistic mixtures of interferons and tumour necrosis factor - Google Patents

Synergistic mixtures of interferons and tumour necrosis factor

Info

Publication number
IL75597A
IL75597A IL75597A IL7559785A IL75597A IL 75597 A IL75597 A IL 75597A IL 75597 A IL75597 A IL 75597A IL 7559785 A IL7559785 A IL 7559785A IL 75597 A IL75597 A IL 75597A
Authority
IL
Israel
Prior art keywords
necrosis factor
interferons
tumour necrosis
synergistic mixtures
interferon
Prior art date
Application number
IL75597A
Other languages
English (en)
Other versions
IL75597A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL75597A0 publication Critical patent/IL75597A0/xx
Publication of IL75597A publication Critical patent/IL75597A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL75597A 1984-06-23 1985-06-21 Synergistic mixtures of interferons and tumour necrosis factor IL75597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843423234 DE3423234A1 (de) 1984-06-23 1984-06-23 Synergistische mischungen von interferonen und tumor-nekrose-faktor

Publications (2)

Publication Number Publication Date
IL75597A0 IL75597A0 (en) 1985-10-31
IL75597A true IL75597A (en) 1991-11-21

Family

ID=6238998

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75597A IL75597A (en) 1984-06-23 1985-06-21 Synergistic mixtures of interferons and tumour necrosis factor

Country Status (16)

Country Link
US (1) US4791101A (cg-RX-API-DMAC7.html)
EP (1) EP0170843B1 (cg-RX-API-DMAC7.html)
JP (1) JPS6115842A (cg-RX-API-DMAC7.html)
AT (1) ATE82508T1 (cg-RX-API-DMAC7.html)
AU (2) AU593212B2 (cg-RX-API-DMAC7.html)
CA (1) CA1258426A (cg-RX-API-DMAC7.html)
DD (2) DD238725A5 (cg-RX-API-DMAC7.html)
DE (2) DE3423234A1 (cg-RX-API-DMAC7.html)
DK (1) DK282585A (cg-RX-API-DMAC7.html)
GR (1) GR851492B (cg-RX-API-DMAC7.html)
HU (1) HU206270B (cg-RX-API-DMAC7.html)
IE (1) IE59289B1 (cg-RX-API-DMAC7.html)
IL (1) IL75597A (cg-RX-API-DMAC7.html)
NZ (1) NZ212513A (cg-RX-API-DMAC7.html)
PH (1) PH24406A (cg-RX-API-DMAC7.html)
ZA (1) ZA854682B (cg-RX-API-DMAC7.html)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
AU601675B2 (en) * 1984-12-21 1990-09-20 Biogen, Inc. Purification, production and use of tumor necrosis factors
NZ219027A (en) * 1986-01-24 1989-09-27 Genentech Inc Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin
US4828830A (en) * 1986-01-24 1989-05-09 Genentech, Inc. Method and composition for prophylaxis and treatment of viral infections
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
CA1291706C (en) * 1986-04-03 1991-11-05 Alfred Rudolph COMBINATION THERAPY USING INTERFERON-.beta. AND INTERLEUKIN-2
US5425940A (en) * 1986-04-09 1995-06-20 Cetus Oncology Corporation Combination therapy using interleukin-2 and tumor necrosis factor
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
PT85076B (pt) * 1986-06-16 1990-07-31 Genentech Inc Metodo para o tratamento de doencas infecciosas pela administracao de factor de necrose tumoral-alfa
US5362490A (en) * 1986-07-25 1994-11-08 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Human myelomonocyte interferon-gamma, and process for preparation and use thereof
IL80005A (en) * 1986-09-10 1992-11-15 Yeda Res & Dev Compositions for modulating the effect of tnf and il-1
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
US4980160A (en) * 1986-10-16 1990-12-25 Biogen, Inc. Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
US4963354A (en) * 1987-01-21 1990-10-16 Genentech, Inc. Use of tumor necrosis factor (TNF) as an adjuvant
ES2034790T3 (es) * 1989-04-11 1993-04-01 Boehringer Ingelheim International Gmbh Empleo de al menos una citroquina para la preparacion de un medicamento para el tratamiento sistematico de lesiones preneoplasticas.
US6042837A (en) * 1989-09-20 2000-03-28 Kalland; Terje Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)
US6126945A (en) * 1989-10-03 2000-10-03 Pharmacia Ab Tumor killing effects of enterotoxins, superantigens, and related compounds
US5676942A (en) * 1992-02-10 1997-10-14 Interferon Sciences, Inc. Composition containing human alpha interferon species proteins and method for use thereof
CA2129533A1 (en) * 1992-02-10 1993-08-19 Douglas Testa Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
EP0783891B1 (en) * 1995-07-25 2006-12-27 Toray Industries, Inc. Interferon-beta for bone diseases
US6617171B2 (en) * 1998-02-27 2003-09-09 The General Hospital Corporation Methods for diagnosing and treating autoimmune disease
US6599710B1 (en) 1999-03-10 2003-07-29 The General Hospital Corporation Treatment of autoimmune disease
US20020091095A1 (en) * 1999-12-13 2002-07-11 Phillips Nigel C. Modulation of Fas and FasL expression
JP4772245B2 (ja) * 1999-12-13 2011-09-14 バイオニケ ライフ サイエンシーズ インコーポレイテッド 治療上有用な合成オリゴヌクレオチド
US7309694B2 (en) * 2000-02-15 2007-12-18 Fondazione Centro San Raffaele Del Monte Tabor Modified cytokines for use in cancer therapy
US7109303B2 (en) * 2000-02-15 2006-09-19 Fondazione Centro San Raffaele Del Monte Tabor Modified cytokines for use in cancer therapy
IT1317835B1 (it) * 2000-02-15 2003-07-15 San Raffaele Centro Fond Citochine modificate per uso nella terapia del cancro.
EP1318834A2 (en) * 2000-09-12 2003-06-18 Genetrol Biotherapeutics, Inc. Compositions comprising mixtures of human cytokines and methods of producing the same
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
DE60316407T2 (de) * 2002-02-06 2008-06-19 Ares Trading S.A. Tumornekrosefaktor in kombination mit interferon zur behandlung und/oder verhinderung einer demyelinisierenden krankheit
GB0209893D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
GB0209896D0 (en) * 2002-04-30 2002-06-05 Molmed Spa Conjugate
US7628988B2 (en) 2002-06-27 2009-12-08 The General Hospital Corporation Methods and compositions for treating type 1 diabetes
US7582313B2 (en) * 2002-06-27 2009-09-01 The General Hospital Corporation Methods of organ regeneration using Hox 11-expressing pluripotent cells
WO2004045376A2 (en) * 2002-11-15 2004-06-03 The General Hospital Corporation Screening methods to identify treatments for autoimmune disease
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
EP1691852A2 (en) * 2003-11-10 2006-08-23 Angiotech International AG Medical implants and fibrosis-inducing agents
US20080102054A1 (en) * 2005-01-18 2008-05-01 Faustman Denise L Compositions Containing Agm Cells And Methods Of Use Thereof
DE102012024749A1 (de) 2012-12-11 2014-06-26 Martin Röcken Tumorprävention und -therapie durch Induktion einer Tumorseneszenz
EP2953634B1 (en) 2013-02-07 2021-05-26 The General Hospital Corporation Methods for expansion or depletion of t-regulatory cells
CN105829885B (zh) 2013-10-17 2020-08-18 综合医院公司 鉴定响应于用于自身免疫性疾病的治疗的受试者的方法以及用于治疗该疾病的组合物
FI3447075T3 (fi) 2015-05-15 2023-11-07 Massachusetts Gen Hospital Antagonistisia anti-tuumorinekroositekijäreseptorin superperheen vasta-aineita
US20190135929A1 (en) 2015-08-28 2019-05-09 The General Hospital Corporation Agonistic anti-tumor necrosis factor receptor 2 antibodies
US11266730B2 (en) 2015-09-29 2022-03-08 The General Hospital Corporation Methods of treating and diagnosing disease using biomarkers for BCG therapy
AU2017263833B2 (en) 2016-05-13 2023-08-03 The General Hospital Corporation Antagonistic anti-tumor necrosis factor receptor superfamily antibodies
JP7534215B2 (ja) * 2018-01-24 2024-08-14 ベイジン パーカンズ オンコロジー カンパニー リミテッド サイトカイン融合タンパク質
CN114436088A (zh) * 2020-11-02 2022-05-06 奥的斯电梯公司 用于电梯轿厢的安全出口组件及电梯系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
JPH0764744B2 (ja) * 1981-11-21 1995-07-12 株式会社林原生物化学研究所 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤
ZA844070B (en) * 1983-06-01 1984-12-24 Genentech Inc Gamma interferon-lymphotoxin synergism
CA1265444A (en) * 1983-06-27 1990-02-06 Lloyd J. Old Effect of human tumor necrosis factor and human interferon on human cancer cells and methods
DE3421731A1 (de) * 1984-06-12 1985-12-12 Boehringer Ingelheim International GmbH, 6507 Ingelheim Humaner-tumor-nekrose-faktor
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor

Also Published As

Publication number Publication date
HUT37891A (en) 1986-03-28
ATE82508T1 (de) 1992-12-15
AU593212B2 (en) 1990-02-08
IL75597A0 (en) 1985-10-31
HU206270B (en) 1992-10-28
DD250053A5 (de) 1987-09-30
AU4416785A (en) 1986-01-02
DK282585D0 (da) 1985-06-21
IE59289B1 (en) 1994-02-09
IE851547L (en) 1985-12-23
GR851492B (cg-RX-API-DMAC7.html) 1985-11-25
PH24406A (en) 1990-06-13
DE3586833D1 (de) 1992-12-24
EP0170843A1 (de) 1986-02-12
JPS6115842A (ja) 1986-01-23
DD238725A5 (de) 1986-09-03
AU4393185A (en) 1986-01-02
CA1258426A (en) 1989-08-15
DK282585A (da) 1985-12-24
DE3423234A1 (de) 1986-02-06
NZ212513A (en) 1988-08-30
US4791101A (en) 1988-12-13
EP0170843B1 (de) 1992-11-19
ZA854682B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
IL75597A (en) Synergistic mixtures of interferons and tumour necrosis factor
FI863160A0 (fi) Anlaeggning foer fiskodling i havsvatten.
DK545584A (da) Enzym-resistente immonumodulatoriske peptider
DE3381553D1 (de) Synergistische humaninterferonaktivitaet.
FI830708A7 (fi) 1,2,4-triatsiini- ja pyratsiinijohdannaiset.
IT8348746A0 (it) Derivati amminometil-benzenici arilsostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni che li contengono
DE3685484D1 (cg-RX-API-DMAC7.html)
DE3479290D1 (en) Synergistic composition comprising gamma interferon and lymphotoxin, and its preparation
IT8419681A0 (it) Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche.
IT8347557A0 (it) Polipeptide avente attivita' di interferon, composizione che lo conti ene e procedimento di preparazione
ATE111357T1 (de) Synergetische immunostimulierende zusammensetzung und ihre verwendung.
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
ATE89569T1 (de) Haemoglobin mit reduziertem virusrisiko und dessen herstellung.
IT1237087B (it) N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
Akande Anhydrobiosis in corticolous bryophytes.
IT209247Z2 (it) Struttura di scudo da difesa, in particolare del tipo antiproiettili.
IT8523222A0 (it) Struttura legnosa multistrato, opportunamento curvata e lavorata, per la realizzazione di letti di tipo anatomico.
FI844769A7 (fi) Vasikan rehu ja siinä käytettävä lisäaine.
IT8522726A0 (it) Composto ad attivita' antivirale e composizioni che lo contengono.
IT8460508V0 (it) Poltroncina metallica perfezionata.
DK606483D0 (da) Synergistisk kombination med cytostatisk virkning
ZA872562B (en) Combination therapy using interleukin-2 and/or interferon-beta and tumor necrosis factor
MX9203709A (es) Composicion citotoxica sinergistica.
IT8423718A0 (it) Impiego di acciai temprabili nichel-martensite per le lame di armi da taglio e da punta.
MY110041A (en) Composition and method of treating hepatitis c

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force